期刊文献+

负载抗原DC与CIK共培养逆转肝癌细胞多药耐药性研究

Reversion of CIK combined with antigen-loaded DC on multidrug resistant hepatocarcinoma HepG2/ADM cells
下载PDF
导出
摘要 目的研究负载抗原的树突状细胞(DC)联合细胞因子诱导的杀伤细胞(CIK)对肝癌细胞株HepG2/ADM多药耐药性的逆转作用。方法 HepG2/ADM细胞冻融抗原冲击DC,联合CIK细胞与HepG2/ADM细胞共培养,以未负载抗原的DCCIK作为阴性对照,以未经共培养处理的HepG2/ADM细胞作为空白对照。采用流式细胞仪在细胞处理后不同时间点检测HepG2/ADM细胞内罗丹明-123(R-123)浓度和阿霉素(ADM)浓度,采用Western blot检测细胞内P-糖蛋白(P-gp)水平。结果与DC-CIK共培养相比,负载抗原的DC-CIK共培养能够明显抑制HepG2/ADM细胞内R-123的外排,提高细胞内ADM浓度,同时降低细胞内P-gp水平(P<0.05)。结论经抗原冲击的DC和CIK共培养可明显抑制HepG2/ADM细胞内R-123的外排,提高细胞内ADM浓度,抑制P-gp表达,从而有效逆转肝癌细胞多药耐药性。 Objective To analyze the reversal effects of antigen‐loaded dendritic cells (DC ) and cytokine‐induced killer cells (CIK) on multidrug resistance of hepatocarcinoma line HepG2/ADM cells .Methods DC were impacted with HepG2/ADM cell ly‐sages and were co‐cultured with CIK .Intracellular concentration of rhodamine‐123(R‐123) and adriamycin(ADM ) were determined by flow cytometry ,and the expression of P‐glycoprotein(P‐gp) was detected by Western blot .Results Compared with non‐antigen‐loaded DC‐CIK ,antigen‐loaded DC‐CIK remarkably increased the intracellular concentration of R‐123 ,and increased the concentra‐tion of ADM ,as well as decreased the expression of P‐gp(P〈0 .05) .Conclusion Antigen‐loaded DC‐CIK could increase the concen‐tration of intracellular ADM ,and decrease the expression of P‐gp ,thus could reverse multidrug resistance of hepatocarcinoma cells .
出处 《检验医学与临床》 CAS 2016年第13期1758-1759,共2页 Laboratory Medicine and Clinic
基金 重庆市渝中区科技计划项目(20120225)
关键词 细胞因子诱导的杀伤细胞 树突状细胞 多药耐药性 P-糖蛋白 HEPG2/ADM 细胞株 cytokine-induced killer cell dendritic cell multidrug resistance P-glycoprotein HepG2/ADM cell
  • 相关文献

参考文献10

  • 1刘鹏英,陈龙邦.CIK细胞联合多西紫杉醇对肺腺癌耐药细胞SPC-A1/DTX的体内外杀伤作用的实验研究[J].中国免疫学杂志,2008,24(12):1079-1083. 被引量:8
  • 2蒋东霞,杨晓博,赵婷茹,徐虹,胡杰英,宋永平.CIK细胞体外逆转多药耐药性的研究[J].河南医学研究,2008,17(1):20-22. 被引量:7
  • 3Feng X,Zhao L,Gao S,et al. Increased fucosylation has a pivotal role in multidrug resistance of breast cancer cells through miR-224-3p targeting FUT4 [J]. Gene, 2015,15 (15) : 1514-1520.
  • 4Liu Z, Duan ZJ, Chang JY, et al. Sinomenine sensitizes multidrug-resistant colon cancer ceils (Caco-2) to doxo- rubicin by downregulation of MDR-1 expression [J]. PLoS One, 2014,9(6) : 98560.
  • 5Oliveira Rodrigues FF,Dos Santos RE, de Oliveira AL, et al. Prognostic assessment of polymorphisms of the MDR- 1 and GSTP1 genes in patients with stage Ⅱ and Ⅲ breast cancer submitted to neoadjuvant chemotherapy[J]. Breast J, 2012,18 (2) : 185-187.
  • 6Khan M, Maryam A, Mehmood T, et al. Enhancing activi- ty of anticancer drugs in multidrug resistant tumors by modulating P-glocoprotein through dietary nutraceuticals [J]. Asian Pae J Cancer Prey, 2015,16 (16) : 6831-6839.
  • 7Pan QZ,Wang QJ,Dan JQ,et ai. A nomogram for predic- ting the benefit of adjuvant cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma [J]. Sci Rep,2015,5(18) :9202-9208.
  • 8Zhao X,Ji CY,Liu GQ,et al. Immunomodulatory effect of DC/CIK combined with chemotherapy in multiple myelo- ma and the clinical efficacy[J]. Int J Clin Exp Pathol, 2015,8(10) : 13146-13155.
  • 9Qiu JG, Zhang YJ, Li Y, et al. Trametinib modulates canc- er multidrug resistance by targeting ABCB1 transporter [J]. Oneotarget, 2015,6(17) : 15494-15509.
  • 10Shah AH,Bregy A, Heros DO,et al. Dendritic cell vaccine for recurrent high-grade gliomas in pediatric and adult subjects: clinical trial protocol[J]. Neurosurgery, 2013,73 (5) : 863-867.

二级参考文献17

  • 1石永进,任汉云,岑溪南,朱强,虞积仁.免疫效应细胞促进阿霉素诱导乳腺癌耐药细胞凋亡[J].中华肿瘤杂志,2006,28(3):188-191. 被引量:8
  • 2杨新静,黄建安,雷伟,朱一蓓,张学光.共培养的树突细胞和CIK细胞对肺癌的体内外抑癌作用[J].癌症,2006,25(11):1329-1333. 被引量:30
  • 3孙海,耿建,金洁,陈龙邦.人肺腺癌细胞系SPC-A1多西他赛耐药细胞系的建立及其特性[J].中国癌症杂志,2007,17(4):283-287. 被引量:6
  • 4Geromin D, Bourge J F, Soulie A et al. Glycoprotein 170 induces platelet-activating factor receptor membrane expression and confers tumor cell hypersensitivity to NK-dependent cell lysis [ J]. Immunol, 2004;172 (6) :3604-3611.
  • 5Savas B, Asian G, Gelen T et al. Multidrug resistant malignant melanoma with intracrartial metastasis responding to immunotherapy[ J]. Anticancer Res, 1999; 19(5C) :4413-4420.
  • 6Paredes Lafio A, Blanco Garcia C et al. Expression of proteins associated with multidrug resistance and resistance to chemotherapy in lung cancer [ J]. Arch Bronconeumol, 2007 ;43 ( 9 ) : 479-484.
  • 7Hira A, Watanabe H,Maeda Y et al. Role of P-glycoprotein in accumulation and cytotoxicity of ammbicin and amrubicinol in MDR1 gene-transfected LLC-PK1 cells and human A549 lung adenocarcinoma cells[ J]. Biochem Pharmacol, 2008; 75 (4) : 973-980.
  • 8Ballen K K,Colvin G, Dey B R et al. Cellular immune therapy for refractory cancers: novel therapeutic strategies [ J]. Exp Hematol, 2005; 33(12):1427-1435.
  • 9Thom E S H, Negrin R S, Contag C H. Synergistic antitumor effects of immune cell-viral biotherapy[ J]. Science,2006;311 (5768): 1780-1784.
  • 10Schmidt-Wolf I G H, Lefterova P, Johnston V et al. Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cells[J]. Cell Immunol, 1996; 169(1) :85-90.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部